These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38561707)

  • 21. Targeted exome sequencing strategy (NeoEXOME) for Chinese newborns using a pilot study with 3423 neonates.
    Cao Z; He X; Wang D; Gu M; Suo F; Qiang R; Zhang R; Song C; Wang X; Zhu B; Cao D; Yu H; Qu Y; Shen G; Wu J; Wang P; Wang J; Zhang H; Yan Z; Yu G; Zou L
    Mol Genet Genomic Med; 2024 Jan; 12(1):e2357. PubMed ID: 38284445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High Incidence of Severe Combined Immunodeficiency Disease in Saudi Arabia Detected Through Combined T Cell Receptor Excision Circle and Next Generation Sequencing of Newborn Dried Blood Spots.
    Al-Mousa H; Al-Dakheel G; Jabr A; Elbadaoui F; Abouelhoda M; Baig M; Monies D; Meyer B; Hawwari A; Dasouki M
    Front Immunol; 2018; 9():782. PubMed ID: 29713328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating parents' decisions about next-generation sequencing for their child in the NC NEXUS (North Carolina Newborn Exome Sequencing for Universal Screening) study: a randomized controlled trial protocol.
    Milko LV; Rini C; Lewis MA; Butterfield RM; Lin FC; Paquin RS; Powell BC; Roche MI; Souris KJ; Bailey DB; Berg JS; Powell CM
    Trials; 2018 Jun; 19(1):344. PubMed ID: 29950170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating a Novel Newborn Screening Methodology: Combined Genetic and Biochemical Screenings.
    Yu B; Yang Y; Zhou L; Wang Q
    Arch Med Res; 2024 Feb; 55(2):102959. PubMed ID: 38295467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newborn Screening for Inborn Errors of Metabolism by Next-Generation Sequencing Combined with Tandem Mass Spectrometry.
    Tang C; Li L; Chen T; Li Y; Zhu B; Zhang Y; Yin Y; Liu X; Huang C; Miao J; Zhu B; Wang X; Zou H; Han L; Feng J; Huang Y
    Int J Neonatal Screen; 2024 Mar; 10(2):. PubMed ID: 38651393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular testing in newborn screening: VUS burden among true positives and secondary reproductive limitations via expanded carrier screening panels.
    Cook S; Dunn E; Kornish J; Calderwood L; Campion M; Cusmano-Ozog KP; Tise CG
    Genet Med; 2024 Apr; 26(4):101055. PubMed ID: 38146699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A prospective study of genetic screening of 2 060 neonates by high-throughput sequencing].
    Zhuang D; Wang F; Ding S; Zheng Z; Yu Q; Lyu L; Sun S; Yang R; Que W; Li H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Jun; 40(6):641-647. PubMed ID: 37211996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comprehensive multiplex PCR based exome-sequencing assay for rapid bloodspot confirmation of inborn errors of metabolism.
    Wang W; Yang J; Xue J; Mu W; Zhang X; Wu W; Xu M; Gong Y; Liu Y; Zhang Y; Xie X; Gu W; Bai J; Cram DS
    BMC Med Genet; 2019 Jan; 20(1):3. PubMed ID: 30612563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expanded newborn screening for inherited metabolic disorders and genetic characteristics in a southern Chinese population.
    Lin Y; Zheng Q; Zheng T; Zheng Z; Lin W; Fu Q
    Clin Chim Acta; 2019 Jul; 494():106-111. PubMed ID: 30904546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Newborn screening for Duchenne muscular dystrophy: A two-year pilot study.
    Tavakoli NP; Gruber D; Armstrong N; Chung WK; Maloney B; Park S; Wynn J; Koval-Burt C; Verdade L; Tegay DH; Cohen LL; Shapiro N; Kennedy A; Noritz G; Ciafaloni E; Weinberger B; Ellington M; Schleien C; Spinazzola R; Sood S; Brower A; Lloyd-Puryear M; Caggana M;
    Ann Clin Transl Neurol; 2023 Aug; 10(8):1383-1396. PubMed ID: 37350320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pilot study of newborn screening for six lysosomal diseases in Brazil.
    Kubaski F; Sousa I; Amorim T; Pereira D; Silva C; Chaves V; Brusius-Facchin AC; Netto ABO; Soares J; Vairo F; Poletto E; Trometer J; Souza A; Ranieri E; Polo G; Hong X; Herbst ZM; Burlina A; Gelb MH; Giugliani R
    Mol Genet Metab; 2023; 140(1-2):107654. PubMed ID: 37507255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Newborn screening and molecular features of patients with multiple acyl-CoA dehydrogenase deficiency in Quanzhou, China.
    Lin Y; Zhang W; Chen Z; Lin C; Lin W; Fu Q; Peng W; Chen D
    J Pediatr Endocrinol Metab; 2021 May; 34(5):649-652. PubMed ID: 33823107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parental Views on Newborn Next Generation Sequencing: Implications for Decision Support.
    Moultrie RR; Paquin R; Rini C; Roche MI; Berg JS; Powell CM; Lewis MA
    Matern Child Health J; 2020 Jul; 24(7):856-864. PubMed ID: 32424581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for neonatal inherited metabolic disorders by tandem mass spectrometry in Guangzhou.
    Tang C; Tan M; Xie T; Tang F; Liu S; Wei Q; Liu J; Huang Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 50(4):463-471. PubMed ID: 34704419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis of Classic Homocystinuria in Two Boys Presenting with Acute Cerebral Venous Thrombosis and Neurologic Dysfunction after Normal Newborn Screening.
    Asamoah A; Wei S; Jackson KE; Hersh JH; Levy H
    Int J Neonatal Screen; 2021 Jul; 7(3):. PubMed ID: 34449521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and Validation of a Custom NGS Panel Targeting a Set of Lysosomal Storage Diseases Candidate for NBS Applications.
    La Cognata V; Guarnaccia M; Morello G; Ruggieri M; Polizzi A; Cavallaro S
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3-Methylcrotonyl-CoA carboxylase deficiency newborn screening in a population of 536,008: is routine screening necessary?
    Wang H; Liu S; Wang B; Yang Y; Yu B; Wang L; Wang T
    J Pediatr Endocrinol Metab; 2019 Dec; 32(12):1321-1326. PubMed ID: 31730530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pilot study of newborn screening for X-linked adrenoleukodystrophy based on liquid chromatography-tandem mass spectrometry method for detection of C26:0-lysophosphatidylcholine in dried blood spots: Results from 43,653 newborns in a southern Chinese population.
    Tang C; Tang F; Cai Y; Tan M; Liu S; Xie T; Jiang X; Huang Y
    Clin Chim Acta; 2024 Jan; 552():117653. PubMed ID: 37977233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current Status of Genetic Diagnosis Laboratories and Frequency of Genetic Variants Associated with Cystic Fibrosis through a Newborn-Screening Program in Turkey.
    Bozdogan ST; Mujde C; Boga I; Sonmezler O; Hanta A; Rencuzogullari C; Ozcan D; Altintas DU; Bisgin A
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33572515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of Next-Generation Sequencing Following Tandem Mass Spectrometry to Expand Newborn Screening for Inborn Errors of Metabolism: A Multicenter Study.
    Yang Y; Wang L; Wang B; Liu S; Yu B; Wang T
    Front Genet; 2019; 10():86. PubMed ID: 30838026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.